Thursday December 02, 2021

Oxford Covid vaccine safe for adults

November 20, 2020

PARIS: A leading Covid-19 vaccine candidate has shown to safely produce a robust immune response in healthy older adults, its British makers said on Thursday as it released its phase 2 trial results. The vaccine, developed by the University of Oxford and AstraZeneca, produced fewer side effects in people aged 56 and over than in younger people -- a significant finding given that Covid-19 disproportionately causes severe illness among seniors.